Beyond Observation: Validating the Ecological Relevance of the Ad-AHA Stroke Using Sensor-Based Measures
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorKU Leuven
About this trial
After a stroke, many people experience difficulty using both hands together in daily life. Most rehabilitation assessments, however, only measure how the affected arm performs in one-handed tasks. This makes it difficult to understand how well people actually use their hands in real-world activities, which are usually bimanual.
The Adult Assisting Hand Assessment - Stroke version (Ad-AHA Stroke) is a new clinical test that evaluates how the affected hand performs during two-handed tasks. While promising, it is still unknown whether the score on this test truly reflects how stroke survivors use their hands in daily life.
This study aims to investigate this question by comparing Ad-AHA Stroke scores with real-life data on hand use, recorded over three days using wrist-worn sensors on both arms. By combining clinical and sensor-based measures, this study will help determine whether the Ad-AHA Stroke can accurately represent everyday bimanual performance after stroke.
Eligibility criteria
Qualifiers
Written informed consent obtained prior to any study procedures.
Age between 18 and 80 years (inclusive).
Unilateral supratentorial stroke involving cortical or subcortical structures.
At least 6 months post-stroke at the time of inclusion.
Disqualifiers
Severe upper limb impairment, defined as a Fugl-Meyer Assessment of Upper Extremity (FMA-UE) score ≤ 15.
Severe cognitive or language comprehension impairment interfering with understanding of study instructions or task performance, as judged during screening.
Presence of other neurological or orthopedic conditions affecting upper limb function (e.g., Parkinson's disease, multiple sclerosis, severe osteoarthritis, brachial plexus injury).
Trial design
Treatments tested in this trial
- Sensor-based monitoring and clinical assessment
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov